Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Alibaba
BABA
|
+$138M |
| 2 |
AbbVie
ABBV
|
+$122M |
| 3 |
Zoom
ZM
|
+$109M |
| 4 |
Amazon
AMZN
|
+$105M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$103M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
Newmont
NEM
|
+$52.9M |
| 4 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 5 |
Yum! Brands
YUM
|
+$34.4M |
Sector Composition
| 1 | Technology | 25.6% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 12.49% |
| 4 | Communication Services | 10.4% |
| 5 | Industrials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CALA
2351
DELISTED
Calithera Biosciences, Inc
CALA
| $572K | ﹤0.01% |
+5,415
| New | +$572K |
|
|
OGI
2352
Organigram Holdings
OGI
$222M
| $571K | ﹤0.01% |
92,000
+17,025
| +23% | +$106K |
|
2353
Hyster-Yale Materials Handling
HY
$634M
| $564K | ﹤0.01% |
14,600
+2,300
| +19% | +$88.8K |
|
2354
Expro
XPRO
$1.43B
| $562K | ﹤0.01% |
41,983
+13,233
| +46% | +$177K |
|
2355
Franklin Covey
FC
$240M
| $561K | ﹤0.01% |
26,200
+7,500
| +40% | +$161K |
|
|
ACBI
2356
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $561K | ﹤0.01% |
46,100
+3,600
| +8% | +$43.8K |
|
2357
Akero Therapeutics
AKRO
$3.48B
| $558K | ﹤0.01% |
+22,400
| New | +$558K |
|
2358
Astronics
ATRO
$1.41B
| $557K | ﹤0.01% |
52,755
+7,900
| +18% | +$83.4K |
|
2359
SunCoke Energy
SXC
$654M
| $553K | ﹤0.01% |
186,950
+18,700
| +11% | +$55.3K |
|
2360
TrueCar
TRUE
$215M
| $553K | ﹤0.01% |
214,200
+51,600
| +32% | +$133K |
|
2361
KRONOS Worldwide
KRO
$694M
| $550K | ﹤0.01% |
52,800
+8,400
| +19% | +$87.5K |
|
2362
Boston Omaha
BOC
$425M
| $547K | ﹤0.01% |
34,163
+17,363
| +103% | +$278K |
|
2363
Capital City Bank Group
CCBG
$739M
| $547K | ﹤0.01% |
26,100
+2,100
| +9% | +$44K |
|
2364
Civitas Resources
CIVI
$3.02B
| $545K | ﹤0.01% |
36,800
+7,200
| +24% | +$107K |
|
2365
Village Super Market
VLGEA
$580M
| $543K | ﹤0.01% |
19,600
+3,100
| +19% | +$85.9K |
|
2366
Five Point Holdings
FPH
$417M
| $541K | ﹤0.01% |
117,700
+17,700
| +18% | +$81.4K |
|
2367
Dillards
DDS
$8.97B
| $536K | ﹤0.01% |
20,800
+500
| +2% | +$12.9K |
|
2368
Ribbon Communications
RBBN
$676M
| $535K | ﹤0.01% |
136,174
+28,800
| +27% | +$113K |
|
|
LCI
2369
DELISTED
Lannett Company, Inc.
LCI
| $535K | ﹤0.01% |
18,425
+2,975
| +19% | +$86.4K |
|
2370
Phathom Pharmaceuticals
PHAT
$840M
| $530K | ﹤0.01% |
+16,100
| New | +$530K |
|
|
LORL
2371
DELISTED
Loral Space and Communications, Inc.
LORL
| $525K | ﹤0.01% |
26,900
+4,300
| +19% | +$83.9K |
|
2372
Revolve Group
RVLV
$1.59B
| $523K | ﹤0.01% |
35,200
+9,300
| +36% | +$138K |
|
2373
Stoke Therapeutics
STOK
$1.29B
| $522K | ﹤0.01% |
21,900
+6,300
| +40% | +$150K |
|
|
CNBKA
2374
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $521K | ﹤0.01% |
6,700
+1,100
| +20% | +$85.5K |
|
|
AMAG
2375
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $521K | ﹤0.01% |
68,157
+3,700
| +6% | +$28.3K |
|